AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

List of Valsoft Anju TrialMaster Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Fgk Clinical Research Life Sciences 170 $30M Germany Valsoft Corporation Valsoft Anju TrialMaster Clinical Trial Management 2019 n/a
In 2019, FGK Clinical Research implemented Valsoft Anju TrialMaster for Clinical Trial Management to support its CRO operational and clinical data management services in Munich, Germany. The agreement established a five-year deployment to provision Valsoft Anju TrialMaster alongside complementary eClinical modules across FGK study operations. The implementation included TrialMaster EDC, IRTMaster, and Acuity Analytics, with configuration work focused on EDC case report form management, randomization and drug supply orchestration through IRTMaster, and centralized reporting via Acuity Analytics. Onboarding and system configuration were managed locally with professional services support from OmniComm Anju, aligning product setup to FGK clinical data management workflows. Integrations emphasized tighter EDC to IRT data flows to reduce redundant data entry and streamline site workflows, placing operational coverage on clinical data management and site operations across FGK's trial portfolio. Governance and rollout were coordinated through local onboarding activities and professional services oversight, enabling synchronized site activation and consistent EDC configuration while improving data orchestration between EDC and IRT systems.
Gustave Roussy France Healthcare 3200 $420M France Valsoft Corporation Valsoft Anju TrialMaster Clinical Trial Management 2017 n/a
In 2017 Gustave Roussy France implemented Valsoft Anju TrialMaster as its Clinical Trial Management platform to centralize oncology clinical trial data across its Paris-area campuses. The deployment positioned TrialMaster EDC as the primary system for managing complex study designs, including umbrella, basket, and other platform trials in oncology research. The implementation emphasized electronic data capture and study configuration capabilities typical of Clinical Trial Management systems, enabling protocol-driven CRF construction, data validation, and query workflows for multicohort oncology protocols. Valsoft Anju TrialMaster was configured to support complex study schemas and iterative protocol amendments common to platform trial operations. Operational coverage extended to clinical operations, data management, and study teams at Gustave Roussy’s Paris-area sites, supporting end-to-end oncology study conduct and readiness for regulatory submission. The deployment served as the authoritative EDC for trial data capture and study submission preparation, with TrialMaster integrated into routine research operations rather than as a point solution. Gustave Roussy renewed its TrialMaster contract in January 2022 after five years of use, with the renewal noting improved efficiency, scalability, and faster study submission readiness in oncology research. The renewal underscores continued governance and operational commitment to Valsoft Anju TrialMaster as the core Clinical Trial Management system for complex oncology trials.
Symbio Life Sciences 188 $38M United States Valsoft Corporation Valsoft Anju TrialMaster Clinical Trial Management 2019 n/a
In 2019, Symbio deployed Valsoft Anju TrialMaster as its Clinical Trial Management solution under a five-year agreement to use OmniComm's TrialMaster EDC. The initiative was scoped to develop and manage clinical study databases for Symbio's global CRO services and to support the company’s European expansion, with selection drivers including fast study-build capability and reliable randomization. Valsoft Anju TrialMaster was configured to support electronic data capture workflows, rapid study-build processes, electronic case report form generation, and integrated randomization functionality. Configuration emphasis was placed on reusable CRF templates, standardized study-build procedures, and streamlined database update paths to enable submission-ready CRFs for sponsor clients. Operational coverage included Symbio’s clinical operations and data management functions across its U.S. base and expanding European activities, aligned under the five-year contract governance. The rollout prioritized centralized build standards and sponsor deliverable readiness, aiming to deliver faster database builds, easier updates, and submission-ready CRFs for sponsor clients.
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Valsoft Anju TrialMaster

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Valsoft Anju TrialMaster. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Valsoft Anju TrialMaster Coverage

Valsoft Anju TrialMaster is a Clinical Trial Management solution from Valsoft Corporation.

Companies worldwide use Valsoft Anju TrialMaster, from small firms to large enterprises across 21+ industries.

Organizations such as Gustave Roussy France, Symbio and Fgk Clinical Research are recorded users of Valsoft Anju TrialMaster for Clinical Trial Management.

Companies using Valsoft Anju TrialMaster are most concentrated in Healthcare and Life Sciences, with adoption spanning over 21 industries.

Companies using Valsoft Anju TrialMaster are most concentrated in France, United States and Germany, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Valsoft Anju TrialMaster across Americas, EMEA, and APAC.

Companies using Valsoft Anju TrialMaster range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 66.67%, large organizations with 1,001-10,000 employees - 33.33%, and global enterprises with 10,000+ employees - 0%.

Customers of Valsoft Anju TrialMaster include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Valsoft Anju TrialMaster customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.